ODTX TPG GP A, LLC bought Odyssey Therapeutics, Inc. shares — SEC Form 4BUYOdyssey Therapeutics, Inc.

The stock is currently trading 11.55% below its 52-week high of $20.18, though it remains 14.64% above the 52-week low of $15.57, putting it in a consolidation range near the insider purchase price of $18.00.

• •The stock traded lower during its debut on May 11, 2026, despite raising $454 million, which may present a buying opportunity if the market overreacts.
• •A cluster of six other insiders bought shares in the last 30 days, creating a momentum setup that traders should monitor for follow-through buying.

• •The stock traded lower during its debut on May 11, 2026, despite raising $454 million, indicating potential volatility or lack of immediate market enthusiasm for the IPO.
• •Additionally, the industry's 90-day buying percentage is only 2.35%, significantly lower than the insider cluster activity, suggesting the broader market may not be fully aligned with the insider sentiment.